June 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

Etoposide Valsartan Tablets May 9, 2012 Products Affected - Description Diovan tablets, Novartis 40 mg, 100 count, unit-dose (NDC 00078-0423-06) 320 mg, 90 count (NDC 00078-0360-34) Reason for the Shortage • Novartis is the sole supplier of valsartan tablets. • Novartis could not provide a reason for the shortage. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=891 Source website: www.ashp.org Rocuronium Injection May 9, 2012 Products Affected - Description Rocuronium 10mg/mL injection, APP 5 mL vials, package of 10 (NDC 63323-0426-05) 10 mL vials, package of 10 (NDC 63323-0426-10) Rocuronium 10 mg/mL injection, Hospira 5 mL Novaplus vials, package of 10 (NDC 00409-9558-49) 5 mL vials, package of 10 (NDC 00409-9558-05) 10 mL vials, package of 10 (NDC 00409-9558-10) 10 mL Novaplus vials, package of 10 (NDC 00409-9558-50) Rocuronium 10 mg/mL injection, Sandoz 5 mL vials, package of 10 (NDC 00781-3220-95) 10 mL vials, package of 10 (NDC 00781-3220-92) Rocuronium 10 mg/mL injection, Teva 5 mL vials, package of 10 (NDC 00703-2394-03) 10 mL vials, package of 10 (NDC 00703-2395-03) Zemuron 10 mg/mL, Merck 5 mL vials, package of 10 (NDC 00052-0450-15) 10 mL vials, package of 10 (NDC 00052-0450-16) Reason for the Shortage • Merck (formerly Schering-Plough) acquired Zemuron from Organon on July 1, 2008. The 5 mL vials were on back order at the time the company acquired the product. Some generic products have had intermittent supply problems due to increased demand for product. • Mylan Institutional (formerly Bioniche) acquired multiple products from Generamedix, including rocuronium. Mylan Institutional states the reason for the shortage was • increased demand. • Hospira has rocuronium on shortage due to a raw materials shortage. • Teva has rocuronium on shortage due to manufacturing delays. • APP and Sagent cite increased demand as the reason for this shortage. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=434 Source website: www.ashp.org 40
Milrinone Injection May 9, 2012 Products Affected - Description Milrinone injection, APP 1 mg/mL, 20 mL vial (NDC 63323-0617-20) 1 mg/mL, 50 mL vial (NDC 63323-0617-50) Milrinone injection, Baxter 0.2 mg/mL, 200 mL premixed bags (NDC 00338-6011-37) Milrinone injection, Bedford 1 mg/mL, 10 mL vial (NDC 55390-0019-10) 1 mg/mL, 20 mL vial (NDC 55390-0020-10) 1 mg/mL, 50 mL vial (NDC 55390-0021-10) 1 mg/mL, 10 mL Novaplus vial (NDC 55390-0074-10) 1 mg/mL, 20 mL Novaplus vial (NDC 55390-0075-10) 1 mg/mL, 50 mL Novaplus vial (NDC 55390-0076-01) 0.2 mg/mL, 100 mL premixed bags (NDC 55390-0078-01) 0.4 mg/mL, 100 mL premixed bags (NDC 55390-0079-01) Milrinone injection, Hospira 0.4 mg/mL, 100 mL premixed bags (NDC 00409-2776-02) 0.2 mg/mL, 100 mL premixed bags (NDC 00409-2776-23) Milrinone injection, West-Ward 0.2 mg/mL, 100 mL premixed bags (NDC 00143-9719-10) 0.2 mg/mL, 200 mL premixed bags (NDC 00143-9718-10) 1 mg/mL, 10 mL vial (NDC 10019-0070-01) - discontinued 1 mg/mL, 20 mL vial (NDC 10019-0070-02) - discontinued 1 mg/mL, 20 mL vial (NDC 00143-9709-10) 1 mg/mL, 20 mL vial (NDC 00641-6067-10) Reason for the Shortage • APP states the reason for the shortage is increased demand for the product. • West-Ward cannot provide a reason for the shortage. • Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011 on a temporary basis. Product will become available in stages as production resumes. • Bedford Laboratories has temporarily suspended the distribution of Ben Venue Laboratories manufactured products. Availability of products is updated on the Bedford Laboratories website. • Apotex, Bioniche, and Teva discontinued milrinone 1 mg/mL vials. • Sanofi-Aventis discontinued Primacor injection. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=741 Source website: www.ashp.org Metformin Oral Tablets May 9, 2012 Products Affected - Description Metformin tablets, Amneal 500 mg extended release, 90 count (NDC 53746-0178-90) - discontinued 500 mg, 1000 count (NDC 65162-0175-11) 41
Page 1 and 2: June 2012 Drug Information Update
Page 3 and 4: First-Time Generics GENERIC DRUG NA
Page 5 and 6: ANTI-DIARRHEALS OPIUM TINCTURE DISP
Page 7 and 8: indicated for the treatment of HIV-
Page 9 and 10: Source website: http://www.fda.gov/
Page 11 and 12: Testosterone Chases Viagra in Libid
Page 13 and 14: Analytical Trend Troubles Scientist
Page 15 and 16: Testosterone supplements may help m
Page 17 and 18: voted 19-3 to endorse the drug's us
Page 19 and 20: New Drug Trial Seeks to Stop Alzhei
Page 21 and 22: translates into a 38 percent reduct
Page 23 and 24: atypical fractures of the thigh bon
Page 25 and 26: contain Sibutramine, an appetite su
Page 27 and 28: 2 fl oz UPC 011673257424. Recall #
Page 29 and 30: NDC 5816082101 (single dose vial);
Page 31 and 32: Manufacturer: Catalent Argentina S.
Page 33 and 34: • Fera cannot provide a reason fo
Page 35 and 36: • Akorn states the reason for the
Page 37 and 38: Reason for the Shortage • Teva st
Page 39: 15 gram Novaplus bulk vial, 1 count
Page 43 and 44: • Ranbaxy has all discontinued me
Page 45 and 46: Doxorubicin Liposomal Injection May
Page 47 and 48: 1 mg/mL, 2 mL vial, 25 count (NDC 6
Page 49 and 50: • APP has leucovorin on shortage
Page 51 and 52: • West-Ward acquired Baxter’s o
Page 53 and 54: • Ethinyl estradiol/norethindrone
Page 55 and 56: Potassium chloride for injection, H
Page 57 and 58: Labetalol tablets, Sandoz 100 mg, 1
Page 59 and 60: the gray market. • Ferring has No
Page 61 and 62: Source website: www.ashp.org Loraze
Page 63 and 64: Fentanyl Injection 50 mcg/mL, Hospi
Page 65 and 66: Bupivacaine Injection May 17, 2012
Page 67 and 68: Article link: http://www.ashp.org/D
Page 69 and 70: Heparin Sodium Injection May 18, 20
Page 71 and 72: o Heparin sodium 10 unit/mL, 5 mL l
Page 73 and 74: Article link: http://www.ashp.org/D
Page 75 and 76: • Amphastar and Baxter have disco
Page 77 and 78: Fludarabine Injection May 21, 2012
Page 79 and 80: TheraCys Intravesical Injection, Sa
Page 81 and 82: Nystatin Oral Suspension May 22, 20
Page 83 and 84: discontinued the 1 mg/mL 4 mL vials
Page 85 and 86: 10 gram vial (NDC 63323-0314-61) Va
Page 87 and 88: 10 mg/mL, 10 mL vial (NDC 63323-020
Page 89 and 90: Papaverine injection Reason for the
Page 91 and 92:
• Mylan Institutional (formerly B
Page 93 and 94:
20 mg, 100 count (NDC 00781-1695-01
Page 95 and 96:
4 mL vial (NDC 00641-6008-10) 10 mL
Page 97 and 98:
20 mL vials (NDC 00069-1340-02) Ond
Page 99 and 100:
ecently changed old Baxter to new W
Page 101 and 102:
1 mg/mL, 2 mL vial, 25 count (new N
Page 103 and 104:
250 mg, 100 count unit dose (NDC 00
Page 105 and 106:
Granisetron Hydrochloride Injection
Page 107 and 108:
15 mg/mL, 10 mL vial (NDC 63323-048
Page 109 and 110:
Ampicillin Sulbactam May 30, 2012 P
show all

June 2012 Drug Information Update - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?